pf-04518600
mAbexperimental
Clinical trial activity
8 trials · 11 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
6
Phase 3
1
Phase 4
0
Earliest trial started Apr 23, 2015 (NCT02315066)
Timeline
Indications
Studied for
- Breast Neoplasms · Phase 2
- Carcinoma, Non-Small-Cell Lung · Phase 3
- Carcinoma, Renal Cell · Phase 2
- Carcinoma, Transitional Cell · Phase 3
- Leukemia, Myeloid, Acute · Phase 2
- Lymphoma · Phase 3
- Lymphoma, Follicular · Phase 1
- Neoplasms · Phase 3
- Ovarian Neoplasms · Phase 3
- Prostatic Neoplasms · Phase 1/Phase 2
- Prostatic Neoplasms, Castration-Resistant · Phase 1/Phase 2
Mechanism of action
TNFSF4 inhibitor
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Also known as
- pf-04518600
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05059522 | Phase 3 | Sep 29, 2021 | Pfizer |
| NCT03971409 | Phase 2 | Jul 1, 2019 | Array BioPharma, Breast Cancer Research Foundation, Hoosier Cancer Research Network, Johns Hopkins University, Pfizer, Translational Breast Cancer Research Consortium, University of California, San Francisco |
| NCT03636503 | Phase 1 | Sep 30, 2018 | Harvard University, Pfizer |
| NCT03390296 | Phase 2 | Dec 27, 2017 | Pfizer, University of Texas at Houston |
| NCT03217747 | Phase 1/Phase 2 (Phase 2) | Aug 2, 2017 | Pfizer, University of Texas at Houston |
| NCT03092856 | Phase 2 | Jul 10, 2017 | National Cancer Institute (NCI), University of Southern California |
| NCT02554812 | Phase 2 | Nov 1, 2015 | Pfizer |
| NCT02315066 | Phase 1 | Apr 23, 2015 | Pfizer |
Showing 8 of 8 trials
Page 1 / 1
Organizations
Research & Development (11)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Pfizer | For profit | 7 | 3 | 3 | 2015 |
| University of Texas at Houston | Academic/Hospital | 2 | 2 | 1 | 2017 |
| Array BioPharma | For profit | 1 | 0 | 1 | 2019 |
| Breast Cancer Research Foundation | Academic/Hospital | 1 | 0 | 1 | 2019 |
| Harvard University | Academic/Hospital | 1 | 1 | 1 | 2018 |
| Hoosier Cancer Research Network | Academic/Hospital | 1 | 0 | 1 | 2019 |
| Johns Hopkins University | Academic/Hospital | 1 | 0 | 1 | 2019 |
| National Cancer Institute (NCI) | Government | 1 | 0 | 1 | 2017 |
| Translational Breast Cancer Research Consortium | Academic/Hospital | 1 | 0 | 1 | 2019 |
| University of California, San Francisco | Academic/Hospital | 1 | 1 | 1 | 2019 |
| University of Southern California | Academic/Hospital | 1 | 1 | 1 | 2017 |
11 organizations
Page 1 / 1